PeopleBio (304840) | AccidentalOrder

KOSDAQ · 561 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

13.6B

Rev (2025)

2.9B

Op Inc (2025)

-8.4B

Net Inc (2025)

-16.9B

PBR

0.48

52W

0K~2K

PeopleBio operates in the Pharmaceuticals sector.

Legal name: PeopleBio, Inc.

In fiscal year 2025, PeopleBio (304840) reported revenue of 2.9 billion KRW, down 23.6% from 3.7 billion KRW a year earlier.

Operating profit was -8.4 billion KRW and net income was -16.9 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 13.6 billion KRW, with a P/B of 0.48.

These figures can be verified in the DART filing (receipt no. 20260407003703).

Year	Rev	Op Inc	Net Inc
2025	2.9B	-8.4B	-16.9B
2024	3.7B	-11.5B	-12.2B
2023	4.5B	-15.2B	-17.4B

5 applicable out of 8 items

Short-term Borrowing Decision

합병등종료보고서(자산양수도)

Semi-Annual Report (2026.06)

Checks

5 of 8 checked items currently applicable.

Market Cap & Price: Market cap is below the delisting threshold for 22 consecutive days.

Administrative Designation: 3 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.6% potential dilution.

Capital Increase: 2 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 1 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Short-term Borrowing Decision
2026-08-14	합병등종료보고서(자산양수도)
2026-08-14	Semi-Annual Report (2026.06)
2026-07-31	Collateral Provision Decision
2026-07-31	Collateral Provision Decision